Evidence map›Paper›PMID 41244497›Full record

ArticleACS omega2025

Osseointegration Effects of 3D-Printed Porous Titanium-Tantalum Scaffolds with Different Tantalum Contents.

Guoqiang Liu, Zhiyuan Kong, Zhenyu Jia, Jianhua Wang

Erratum issuedAbstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Guoqiang LiuDepartment of Orthopedics, General Hospital of Southern Theater Command of PLA, No.111 Liuhua Road, Guangzhou 510010, China.
Zhiyuan KongDepartment of Orthopedics, General Hospital of Southern Theater Command of PLA, No.111 Liuhua Road, Guangzhou 510010, China.
Zhenyu JiaDepartment of Orthopedics, General Hospital of Southern Theater Command of PLA, No.111 Liuhua Road, Guangzhou 510010, China.
Jianhua WangThe First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.ORCID https://orcid.org/0000-0003-1992-2761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Titanium (Ti) is known for its excellent corrosion resistance and its biomechanical properties. However, its bioinert nature and high elasticity result in suboptimal osseointegration. In contrast, tantalum (Ta) demonstrates superior osteogenesis and osseointegration but has a high elastic modulus and density, making it costly to process. In the present study, we produced the implantable composite TiTa that combines the advantages of Ti and Ta, which is fabricated by blending Ti powder with 25, 50, and 75% Ta. We designed porous scaffolds with different TiTa ratios while maintaining consistent porosity, pore shape, pore size, and distribution via computer-assisted design (CAD) and fabrication through laser powder bed fusion (LPBF). The results show that the elastic modulus and yield stress of TiTa scaffolds both match the mechanical environment characteristics of human cancellous bone, which can reduce the risk of stress shielding. In vitro experiments showed that TiTa50 and TiTa75 had cell adhesion, proliferation, and osteogenic differentiation abilities comparable to those of Ta in MC3T3-E1 cells. Furthermore, in vivo studies revealed that TiTa50 and TiTa75 achieved bone formation and osseointegration capabilities similar to those of Ta. This indicates that TiTa alloys with up to 50% Ta can achieve osseointegration comparable to that of Ta. Notably, compared to TiTa75, TiTa50 contains a lower proportion of Ta. It not only effectively balances the alloy's processability and formability while safeguarding its bioactivity but also offers substantial cost-saving potential. Consequently, TiTa50 is easier in terms of the preparation process and more cost-effective compared to TiTa75.

Identifiers

PMID41244497
PMCPMC12613119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.